Supriya Lifescience Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Profit before tax

123.49

207.25

167.31

96.75

57.33

Net cashflow-operating activity

66.19

48.80

78.91

116.67

49.01

Net cash used in investing activity

-133.15

-59.82

-46.80

-40.60

5.12

Netcash used in fin. activity

-3.37

149.65

-14.52

-13.76

-50.34

Net inc/dec in cash and equivlnt

-70.33

138.63

17.59

62.31

3.79

Cash and equivalnt begin of year

227.91

89.28

74.71

12.40

8.61

Cash and equivalnt end of year

157.58

227.91

92.29

74.70

12.40